Fusion Antibodies plc
Company Profile
Fusion is a Belfast based contract research organisation ("CRO") providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications.
Investor Access
Management will be providing an update on the business and current trading on on Thursday, 16 May.
Investors can sign up to Investor Meet Company for free and add to meet Fusion Antibodies plc: https://www.investormeetcompany.com/fusion-antibodies-plc/register-investor.
Thursday 16 May at 11.00am
Event | Date |
Year End | 31 March |
Half Year End | 30 September |
Preliminary Results* | August |
Interim Results* | December |
AGM* | June |
* Months based on previous announcements of this kind